Unicycive Therapeutics In...

NASDAQ: UNCY · Real-Time Price · USD
6.21
0.27 (4.55%)
At close: Jun 27, 2025, 10:41 AM

Unicycive Therapeutics Revenue

Unicycive Therapeutics reported an annual revenue of $0, reflecting a -100% growth. For the quarter ending March 31, 2025, Unicycive Therapeutics generated $0 in revenue.
Revenue (ttm)
$0
Revenue Growth
-100%
Price / Sales Ratio
0
Revenue / Employee
$0
Employees
22
Market Cap
749.11M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.